Bioinformatics comes further into spotlight with Illumina, Qiagen buys
This article was originally published in Clinica
Executive Summary
Recent acquisitions by two significant molecular diagnostics players in the bioinformatics space highlight its increasing importance, according to Goldman Sachs analyst Isaac Ro.